¼¼°èÀÇ ¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE) ½ÃÀå : Á¦Ç°º°, ¹æ¹ýº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Cell-free Protein Expression Market Report by Product, Method, Application, End User, and Region 2025-2033
»óǰÄÚµå : 1701884
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 148 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,236,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,648,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,061,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE) ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 2¾ï 8,350¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 5¾ï 1,510¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025³âºÎÅÍ 2033³â±îÁö 6.52%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÁÖ·Î °³ÀÎ ¸ÂÃãÇü ÀÇ·á, ¹é½Å °³¹ß, ÇÕ¼º »ý¹°ÇÐÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. Á¦¾à ¹× »ý¸í°øÇÐ ºÐ¾ß¿¡¼­ ºñ¿ë È¿À²ÀûÀ̰í À¯¿¬ÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó CFPE´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, CFPE´Â Áß¿äÇÑ »ê¾÷ Ȱ¼ºÈ­ ¿äÀÎÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE)Àº ¼¼Æ÷¿¡¼­ ÃßÃâÇÑ »ýü ºÐÀÚ ¹ø¿ª ÀåÄ¡¸¦ »ç¿ëÇÏ¿© ¿ë¾×¿¡¼­ ¿øÇÏ´Â ÀçÁ¶ÇÕ ´Ü¹éÁúÀ» »ý»êÇÏ´Â °ÍÀ» ¸»Çϸç, ´ëÀå±Õ, Åä³¢ ¸Á»ó ÀûÇ÷±¸, ¹Ð ¹è¾Æ, °ïÃæ ¼¼Æ÷, Æ÷À¯·ù ¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE) ½Ã½ºÅÛ µî ´Ù¾çÇÑ ¼¼Æ÷ ¿ëÇØ¹°À» »ç¿ëÇÏ¿© ¼öÇà ÇÒ ¼ö ÀÖ½À´Ï´Ù. CFPE´Â È¿¼Ò°øÇÐ, ´Ü¹éÁú Ç¥Áö, ´Ü¹éÁú Á¤Á¦, ´Ü¹éÁú °£ »óÈ£ÀÛ¿ë, º¯ÀÌüÀÇ °í󸮷® »ý»ê µî¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ´Ü¹éÁúÀÇ ¾ÈÁ¤¼º, ºÐÇØ, Á¢Èû¿¡ ÇÊ¿äÇÑ ¼ººÐ ºÐ¼®¿¡µµ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼¼Æ÷ ±â¹Ý ´Ü¹éÁú ¹ßÇö¿¡ ºñÇØ ¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE)Àº ½Ã°£ È¿À²ÀÌ ³ô°í Æí¸®Çϸç, ºñõ¿¬ ¾Æ¹Ì³ë»êÀ» ÅëÇÕÇÒ ¼ö ÀÖ°í, ¾ÈÁ¤¼º°ú ƯÀ̼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE) ½ÃÀå µ¿Çâ :

»ý¹° °úÇÐÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE)Àº À¯Àü ¾ÏÈ£ÀÇ È®Àå, ¹ÙÀÌ·¯½º Á¶¸³, ´Ù¾çÇÑ »ýü ºÐÀÚ °øÁ¤À» À§ÇÑ ÀçÁ¶ÇÕ ´Ü¹éÁúÀÇ ÇÕ¼º¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Ï ¹× °¨¿° Ä¡·á¸¦ À§ÇÑ Ç×ü, Ç×±ÕÁ¦, »çÀÌÅäÄ«Àΰú °°Àº ´Ü¹éÁú ±â¹Ý Ä¡·áÁ¦¸¦ °³¹ßÇϱâ À§ÇÑ Á¦¾à »ê¾÷¿¡¼­ÀÇ ±â¼ú Ȱ¿ë Áõ°¡´Â ¶Ç ´Ù¸¥ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È¿À²ÀûÀÎ ÇÁ·ÎÅäŸÀÌÇΰú °í󸮷® ½ÇÇèÀ» À§ÇÑ ½Ã½ºÅÛ ÃÖÀûÈ­¸¦ ÅëÇØ ´Ü¹éÁú »ý»ê ¼öÀ²À» Çâ»ó½ÃŰ´Â ¸Ó½Å·¯´×(ML) ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀº ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬¼Ó ±³È¯ ¹«¼¼Æ÷(CECF) ´Ü¹éÁú ÇÕ¼º ½Ã½ºÅÛÀ» »ç¿ëÇÏ¿© º¹ÀâÇÑ ¿øÇÙ »ý¹° ¹× ÁøÇÙ »ý¹° ´Ü¹éÁúÀ» »ý»êÇϱâ À§ÇÑ »õ·Î¿î °øÁ¤ÀÇ µµÀÔÀº ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ´Ù¸¥ ¿äÀÎÀ¸·Î´Â ¹ÙÀÌ¿À Á¦Á¶ ¹× ÇÁ·ÎÅäŸÀÌÇο¡¼­ ¹«¼¼Æ÷ ¹æ¹ýÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃ, ´Ü¹éÁúüÇÐ ¹× À¯ÀüüÇÐÀÇ ±¤¹üÀ§ÇÑ Á¶»ç °³¹ß(R&D) Ȱµ¿, º´¿øÃ¼ °¨Áö, ¿°Áõ ¹ÝÀÀ ¹× °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿Í °°Àº Áø´Ü ÀÀ¿ë ºÐ¾ß¿¡¼­ ÇコÄÉ¾î »ê¾÷¿¡¼­ äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ¹«¼¼Æ÷ ´Ü¹éÁú ¹ßÇö(CFPE) ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ½ÃÀå ºÐ¼® : ¹æ¹ýº°

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦9Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global cell-free protein expression market size reached USD 283.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 515.1 Million by 2033, exhibiting a growth rate (CAGR) of 6.52% during 2025-2033. The market is experiencing significant growth mainly driven by advancements in personalized medicine, vaccine development, and synthetic biology. The rising demand for cost-effective, flexible solutions in pharmaceuticals and biotechnology further propels market growth, positioning CFPE as a key industry enabler.

Cell-free protein expression (CFPE) refers to the production of desired recombinant proteins in solution using biomolecular translation machinery extracted from cells. It can be carried out using different cell lysates, such as E. coli, rabbit reticulocytes, wheat germ, insect cells, and mammalian cell-free protein expression systems. They are widely used in enzyme engineering, protein labeling, protein purification, protein-protein interaction, and high throughput production of mutants. CFPE is also used for analyzing components needed for protein stability, degradation, and folding. As compared to cell-based protein expression, cell-free protein expression is time efficient and convenient, allows the incorporation of non-natural amino acids, and provides enhanced stability and specificity.

Cell-free Protein Expression Market Trends:

The rapid advancement in biological sciences is one of the key factors driving the market growth. Cell-free protein expression is extensively used in the expansion of genetic code, assembly of viruses, and the synthesis of recombinant proteins for various biomolecular processes. Furthermore, the increasing technique utilization in the pharmaceutical industry for developing protein-based therapeutics, such as antibodies, antimicrobials, and cytokines, for treating cancer and infectious diseases is acting as another growth-inducing factor. Additionally, the integration of machine learning (ML) algorithms to improve protein production yield by optimizing the system for efficient prototyping and high-throughput experimentation is providing an impetus to market growth. Moreover, the introduction of novel processes to produce complex prokaryotic and eukaryotic proteins using a continuous-exchange cell-free (CECF) protein synthesis system is creating a positive outlook for the market. Other factors, including the widespread adoption of cell-free methods for biomanufacturing and prototyping, extensive research and development (R&D) activities in proteomics and genomics, and the rising adoption in the healthcare industry for diagnostic applications, such as pathogen sensing, inflammatory response, and personalized medicine, are supporting drive the market growth.

Key Market Segmentation:

Breakup by Product:

Breakup by Method:

Breakup by Application:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioneer Corporation, biotechrabbit GmbH, Cambridge Isotope Laboratories Inc. (Otsuka Pharmaceutical Co. Ltd.), CellFree Sciences Co. Ltd., Cube Biotech GmbH, GeneCopoeia Inc., Jena Bioscience GmbH, Merck KGaA, New England Biolabs, Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Cell-free Protein Expression Market

6 Market Breakup by Product

7 Market Breakup by Method

8 Market Breakup by Application

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â